SCHEMBL9148593

SCHEMBL9148593

CCC(=O)CCNC1CC[N]CC1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.32
TAAR1 Q96RJ0 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9146801 0.81 METAP1 (0.37) TDP1
SCHEMBL16382086 0.81 EPHX1 (0.44) TAAR1
SCHEMBL9145354 0.81 ALDH1A1 (0.33) KDM1ATAAR1
SCHEMBL9233824 0.79 EPHX2 (0.45)
SCHEMBL8851033 0.78 SMYD3 (0.41) TDP1
SCHEMBL8851413 0.78 LMNA (0.41)
SCHEMBL8851151 0.77 ALDH1A1 (0.34) TAAR1
SCHEMBL8851045 0.76 ALDH1A1 (0.40) TDP1
SCHEMBL8850964 0.76 ALDH1A1 (0.41)
SCHEMBL2095567 0.74 GNAI3 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5391556-A Thrombin inhibitors KARL THOMAE GMBH (DE) 1995-02-21 US disclosed
EP-0555824-A1 N-alpha-arylsulfonylated benzimidazolylalaninamide derivatives, medicaments based thereon and process for their preparation Dr. Karl Thomae GmbH (DE) 1993-08-18 EP disclosed